H-1337

· D. Western Therapeutics Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H-1337, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]

See pricing